Skip to main content

Molecular Cytopathology

  • Chapter
  • First Online:
Molecular Surgical Pathology

Abstract

In conjunction with our understanding of the disease, the role of pathologists has evolved from a pure morphologic assessment to a more active participation in triaging specimens for a host of ancillary studies and incorporating these results into the pathology report in order to refine diagnoses and/or guide therapeutic decisions. As molecular characterization of different types of cancer becomes standard of care, pathologists will continue to play a pivotal role in early diagnosis, monitoring of tumor response, and disease progression of cancer patients. The powerful combination of advanced molecular diagnostics and the minimally invasive nature of cytology specimens that define molecular cytopathology, amplifies our ability to do more with less and propels this new field to the forefront of personalized medicine. Given that many patients present with advanced-stage cancers in whom the diagnosis is made only based on cytology, optimizing and validating cytology specimens for molecular testing is critical.

We review in this chapter, the range of cytology specimens and the different ways in which they can be utilized for various molecular tests.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Further Reading

  • Balassanian R, Ng DL, Zante A. Stop using expired plasma for cell blocks. Cancer Cytopathol. 2019;127:737–8.

    Article  PubMed  Google Scholar 

  • Balla A, Hampel KJ, Sharma MK, Cottrell CE, Sidiropoulos N. Comprehensive validation of cytology specimens for next-generation sequencing and clinical practice experience. J Mol Diagn. 2018;20:812–21.

    Article  CAS  PubMed  Google Scholar 

  • Dejmek A, Zendehrokh N, Tomaszewska M, Edsjö A. Preparation of DNA from cytological material: effects of fixation, staining, and mounting medium on DNA yield and quality. Cancer Cytopathol. 2013;121:344–53.

    Article  CAS  PubMed  Google Scholar 

  • Dudley JC, Schroers-Martin J, Lazzareschi DV, et al. Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discov. 2019;9:500–9.

    Article  CAS  PubMed  Google Scholar 

  • Gillooly JF, Hein A, Damiani R. Nuclear DNA content varies with cell size across human cell types. Cold Spring Harb Perspect Biol. 2015;7:a019091.

    Article  PubMed  PubMed Central  Google Scholar 

  • Grace A, Kay E, Leader M. Liquid-based preparation in cervical cytology screening. Curr Diagn Pathol. 2001;7(2):91–5.

    Article  Google Scholar 

  • Guseva NV, Jaber O, Stence AA, Sompallae K, Bashir A, Sompallae R, Bossler AD, Jensen CS, Ma D. Simultaneous detection of single-nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA-based next-generation sequencing assay. Cancer Cytopathol. 2018;126:158–69.

    Article  CAS  PubMed  Google Scholar 

  • Harada S, Agosto-Arroyo E, Levesque JA, Alston E, Janowski KM, Coshatt GM, Eltoum IA. Poor cell block adequacy rate for molecular testing improved with the addition of diff-quik-stained smears: need for better cell block processing. Cancer Cytopathol. 2015;123:480–7.

    Article  PubMed  Google Scholar 

  • Heymann JJ, Yoxtheimer LM, Park HJ, et al. Preanalytic variables in quality and quantity of nucleic acids extracted from FNA specimens of thyroid gland nodules collected in CytoLyt: cellularity and storage time. Cancer Cytopathol. 2020;128:656–72.

    Article  CAS  PubMed  Google Scholar 

  • Hoffman EA, Frey BL, Smith LM, Auble DT. Formaldehyde crosslinking: a tool for the study of chromatin complexes. J Biol Chem. 2015;290:26404–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hwang DH, Garcia EP, Ducar MD, Cibas ES, Sholl LM. Next-generation sequencing of cytologic preparations: an analysis of quality metrics. Cancer Cytopathol. 2017;125:786–94.

    Article  CAS  PubMed  Google Scholar 

  • Jennings LJ, Arcila ME, Corless C, Kamel-Reid S, Lubin IM, Pfeifer J, Temple-Smolkin RL, Voelkerding KV, Nikiforova MN. Guidelines for validation of next-generation sequencing-based oncology panels: a joint consensus recommendation of the Association for Molecular Pathology and College of American pathologists. J Mol Diagn. 2017;19:341–65.

    Article  PubMed  Google Scholar 

  • Kanagal-Shamanna R, Portier BP, Singh RR, et al. Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics. Mod Pathol. 2014;27:314–27.

    Article  CAS  PubMed  Google Scholar 

  • Larson MH, Pan W, Kim HJ, et al. A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection. Nat Commun. 2021;12:2357.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu H, Huang X, Zhang Y, Ye H, El Hamidi A, Kocjan G, Dogan A, Isaacson PG, Du M-Q. Archival fixed histologic and cytologic specimens including stained and unstained materials are amenable to RT-PCR. Diagn Mol Pathol. 2002;11:222–7.

    Article  PubMed  Google Scholar 

  • Masumoto N, Fujii T, Ishikawa M, Mukai M, Saito M, Iwata T, Fukuchi T, Kubushiro K, Tsukazaki K, Nozawa S. Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women. Br J Cancer. 2003;88:1883–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Monaco SE, Dacic S. Fluorescence in situ hybridization in cytopathology. In: Modern techniques in cytopathology, vol. 25. Basel: Karger; 2019. p. 19–33.

    Chapter  Google Scholar 

  • Monaco SE, Teot LA, Felgar RE, Surti U, Cai G. Fluorescence in situ hybridization studies on direct smears: an approach to enhance the fine-needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas. Cancer Cytopathol. 2009;117:338–48.

    Article  CAS  Google Scholar 

  • Pentsova EI, Shah RH, Tang J, et al. Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid. J Clin Oncol. 2016;34:2404–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ramani NS, Chen H, Broaddus RR, et al. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers. Cancer Cytopathol. 2021;129:374–82.

    Article  CAS  PubMed  Google Scholar 

  • Roy-Chowdhuri S, Chen H, Singh RR, et al. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies. Mod Pathol. 2017;30:499–508.

    Article  PubMed  Google Scholar 

  • Roy-Chowdhuri S, Mehrotra M, Bolivar AM, et al. Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling. Mod Pathol. 2018;31:1036–45.

    Article  CAS  PubMed  Google Scholar 

  • Roy-Chowdhuri S, Roy S, Pantanowitz L. Next-generation sequencing in cytopathology. In: Modern techniques in cytopathology, vol. 25. Basel: Karger; 2020. p. 34–42.

    Chapter  Google Scholar 

  • Saqi A, Balassanian R. Cell blocks: evolution, modernization, and assimilation into emerging technologies. In: Modern techniques in cytopathology, vol. 25. Basel: Karger; 2020. p. 6–18.

    Chapter  Google Scholar 

  • Soltani M, Nemati M, Maralani M, Estiar MA, Andalib S, Fardiazar Z, Sakhinia E. Cell-free fetal DNA in amniotic fluid supernatant for prenatal diagnosis. Cell Mol Biol. 2016;62:14–7.

    CAS  PubMed  Google Scholar 

  • Sung S, Sireci A, Remotti H, Hodel V, Mansukhani M, Fernandes H, Saqi A. Plasma-thrombin: potential source of DNA contamination in cell blocks. J Am Soc Cytopathol. 2018;7:S5.

    Article  Google Scholar 

  • Yang S-R, Mooney KL, Libiran P, et al. Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology. Cancer Cytopathol. 2020;128:43–56.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sinchita Roy-Chowdhuri .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ruiz-Cordero, R., Roy-Chowdhuri, S. (2023). Molecular Cytopathology. In: Cheng, L., Netto, G.J., Eble, J.N. (eds) Molecular Surgical Pathology. Springer, Cham. https://doi.org/10.1007/978-3-031-35118-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-35118-1_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-35117-4

  • Online ISBN: 978-3-031-35118-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics